PRESS RELEASE Eli Lilly France: NEW INVESTMENT OF NEARLY €160 MILLION
LILLY FRANCE ANNOUNCES A NEW INVESTMENT OF NEARLY €160 MILLION TO PRODUCE TOMORROW'S INNOVATIVE MEDICINES AT ITS FEGERSHEIM SITE.
Tags in this Article:
Alcobendas at 35: the recipe for success in R&D
Even though Lilly’s R&D centre in Alcobendas only opened in 2002, R&D activity began at the site 35 years ago. The resilience and creativity of the highly qualified team of researchers who began operations allowed the company to build an R&D site that would go on to employ one hundred scientists.